New York State Common Retirement Fund Meridian Bioscience Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$30.9 - $33.55 $18.9 Million - $20.5 Million	-611,669 Reduced 95.27%	30,400 $959,000
Q2 2022 Aug 04, 2022	SELL	$23.75 - $31.69 $117,087 - $156,231	-4,930 Reduced 0.76%	642,069 $19.5 Million
Q1 2022 May 05, 2022	BUY	$19.97 - $26.94 $1,058 - $1,427	53 Added 0.01%	646,999 $16.8 Million
Q4 2021 Feb 02, 2022	SELL	$17.46 - $21.61 $2.03 Million - $2.51 Million	-116,304 Reduced 15.24%	646,946 $13.2 Million
Q3 2021 Nov 02, 2021	SELL	$17.35 - $22.5 $136,631 - $177,187	-7,875 Reduced 1.02%	763,250 $14.7 Million
Q2 2021 Aug 02, 2021	SELL	$18.01 - $28.32 $1.95 Million - $3.07 Million	-108,414 Reduced 12.33%	771,125 $17.1 Million
Q1 2021 May 11, 2021	BUY	$19.76 - $29.89 $16.2 Million - $24.5 Million	819,098 Added 1355.2%	879,539 $23.1 Million
Q3 2020 Nov 05, 2020	SELL	$13.54 - $26.41 $54,660 - $106,617	-4,037 Reduced 6.26%	60,441 $1.03 Million
Q2 2020 Aug 07, 2020	BUY	$7.84 - $23.29 $228,755 - $679,555	29,178 Added 82.66%	64,478 $1.5 Million
Q1 2020 May 06, 2020	BUY	$5.57 - $11.5 $31,192 - $64,400	5,600 Added 18.86%	35,300 $297,000
Q4 2019 Feb 05, 2020	SELL	$7.9 - $10.14 $1.07 Million - $1.37 Million	-135,578 Reduced 82.03%	29,700 $290,000
Q3 2019 Nov 07, 2019	SELL	$9.17 - $12.01 $56,505 - $74,005	-6,162 Reduced 3.59%	165,278 $1.57 Million
Q2 2019 Aug 09, 2019	SELL	$10.88 - $17.6 $107,646 - $174,134	-9,894 Reduced 5.46%	171,440 $2.04 Million
Q4 2018 Feb 08, 2019	SELL	$14.52 - $19.72 $2.12 Million - $2.88 Million	-146,060 Reduced 44.61%	181,334 $3.15 Million
Q3 2018 Nov 07, 2018	SELL	$14.85 - $16.35 $301,618 - $332,084	-20,311 Reduced 5.84%	327,394 $4.88 Million
Q2 2018 Aug 10, 2018	SELL	$13.8 - $16.8 $3 Million - $3.66 Million	-217,629 Reduced 38.5%	347,705 $5.53 Million
Q1 2018 May 10, 2018	SELL	$13.8 - $16.2 $6.81 Million - $8 Million	-493,653 Reduced 46.62%	565,334 $8.03 Million
Q4 2017 Feb 13, 2018	SELL	$13.55 - $15.8 $13,550 - $15,800	-1,000 Reduced 0.09%	1,058,987 $14.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,059,987	1,059,987 $16.7 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account